ONWARD Medical Welcomes Tim Denison to Board of Directors

ONWARD Medical N.V., a leader in neurotechnology, has appointed Professor Tim Denison to its Board of Directors. Denison, known for his role at the University of Oxford and former Vice Presidency at Medtronic, will bring his expertise in neural interface technologies to ONWARD. He succeeds Co-Founder Gregoire Courtine, who will now focus on new initiatives at the Neuro-X Institute and EPFL, while continuing to advise ONWARD.

Denison's background includes co-founding Amber Therapeutics and earning prestigious fellowships in medical and biological engineering. His appointment follows the reappointment of key board members, as confirmed at ONWARD's 2025 General Meeting. The company's strategic leadership changes aim to strengthen its development and market introduction of innovative therapies for spinal cord injuries and movement disabilities.